Search Results 451-460 of 16878 for 4-week HIIT protocol

  1. Gastroenterology and Hepatology - Clinical trials

    The goal of this protocol ... The study also aims to provide a platform for development of an interventional protocol for early detection of PDAC. ... Go to page 44 ...

  2. A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants with Moderately to Severely Active Crohn's Disease (CD) - Mayo Clinic

    At Week 14 (end of Induction Phase), participants achieving decrease of 70 points in Crohn's Disease Activity Index (CDAI) from baseline (CDAI-70 response) ...

  3. Hematology - Clinical trials

    The aim of this study is to study the efficacy and safety of our short and long one-day protocols for TMP-SMX graded administration in hematologic malignancy, ...

  4. PROCEDURE,PROCEDURE RECORD NAME,UNIT CHARGE,UNIT ... 4 VARIANTS,329,329, 300000203,HC IDUA FULL GENE ... PROCEDURE LEVEL 5,50,50, 300000265,HC MPL ...

  5. A Study of BHV-3241 in Subjects with Multiple System Atrophy - Mayo Clinic

    Sponsor Protocol Number: BHV3241-301. About this ... 4 weeks prior to sexual intercourse;; WOCBP must ... Falling more frequently than once per week, as assessed by ...

  6. Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System at Home - Mayo Clinic

    Sponsor Protocol Number: CEP304DOC. About this ... 4 years who have completed participation in the ... weeks. Subject is currently abusing illicit ...

  7. BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma - Mayo Clinic

    ... 4 weeks after treatment discontinuation. Females of childbearing potential must have a negative pregnancy test within 7 days prior to registration for ...

  8. Effects Of Oral Levosimendan (ODM-109) On Respiratory Function In Patients With ALS - Mayo Clinic

    Sponsor Protocol Number: 3119002. About this study ... weeks 18, 30 and 42 ... If using edaravone, the treatment should have been started at least 4 weeks ...

  9. Selinexor, Daratumumab, Carfilzomib and Dexamethasone for the Treatment of High-Risk, Recurrent or Refractory Multiple Myeloma - Mayo Clinic

    Sponsor Protocol Number: ACCRU-MY-1901. About this ... equivalent within 1 week of the ... - Major surgery within 4 weeks prior to day 1 of treatment - ...

  10. post - traumatic stress disorder Archives - Mayo Clinic News Network

    ... WEEK'S TOP STORIES Rev up your workout with interval training Want to burn more calories or simply shake up your workout? Try interval training. It's an ...